TL;DR: Enjamb Labs is a Y Combinator Spring 2026 startup Where drug teams run their entire program, discovery to FDA approval, currently active with a team of 2.
Where drug teams run their entire program, discovery to FDA approval
Last verified:
Enjamb runs the entire drug program for biopharma teams, from discovery to FDA approval. Pharma runs on decades of closed legacy systems like Benchling, Veeva, Medidata, and SAS, with no AI layer and no MCP to connect agents to them. So we built that connection layer in one platform. Our agents run on top of their existing systems and data, with no migration, and do the work across the whole program: clinical evidence, trial design, statistical programming, and regulatory submissions. In just 3 weeks since launch, we're already being used by 500+ employees at top pharma companies, including Johnson & Johnson, AbbVie, Bristol Myers Squibb, Merck & Sanofi.
Yes. Enjamb Labs was funded by Y Combinator in the Spring 2026 batch. Where drug teams run their entire program, discovery to FDA approval
Enjamb runs the entire drug program for biopharma teams, from discovery to FDA approval. Pharma runs on decades of closed legacy systems like Benchling, Veeva, Medidata, and SAS, with no AI layer and no MCP to connect agents to them. So we built that connection layer in one platform. Our agents run on top of their exi…
Enjamb Labs was part of Y Combinator's Spring 2026 batch.
Enjamb Labs has a team of 2 people according to Y Combinator's directory.
Enjamb Labs is currently listed as Active with a team of 2 in Y Combinator's directory.
Loading interactive view…